NEW YORK (GenomeWeb News) – Gene Network Sciences will process clinical data from Biogen Idec to identify targets and biomarkers for inflammation, GNS said today.
 
GNS will use the data to develop a forward-simulation model that Biogen will then license.
 
GNS uses massively parallel supercomputers to search through “vast amounts of raw human biological data” for causes of disease and information about disease treatment, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.